Three equity schemes from top 10 mutual fund schemes have given returns of 50 percent each in the calendar year 2020 so far. We have considered all equity funds with a regular plan and both (open-ended and close ended) schemes. Interestingly, these top 10 MF schemes have offered over 40 percent returns this year so far. (Source: valueresearchonline.com).
DSP World Gold Fund - Regular Plan delivered 51.59 percent return is 2020 so far. The scheme's current net assets value at Rs 772 crore.
DSP Healthcare Fund - Regular Plan delivered 51.32 percent return is 2020 so far. The scheme's current net assets value at Rs 571 crore.
PGIM India Global Equity Opportunities Fund delivered a 50.47 percent return is 2020 so far. The scheme's current net assets value at Rs 194 crore.
Mirae Asset Healthcare Fund - Regular Plan delivered 48.38 percent return is 2020 so far. The scheme's current net assets value at Rs 773 crore.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund delivered a 45.07 percent return is 2020 so far. The scheme's current net assets value at Rs 1,749 crore.
UTI Healthcare Fund - Regular Plan delivered 43.17 percent return is 2020 so far. The scheme's current net assets value at Rs 542 crore.
Motilal Oswal Nasdaq 100 FOF - Regular Plan delivered 43.01 percent return is 2020 so far. The scheme's current net assets value at Rs 868 crore.
Motilal Oswal NASDAQ 100 Exchange Traded Fund delivered a 42.94 percent return is 2020 so far. The scheme's current net assets value at Rs 1,365 crore.
Nippon India Pharma Fund delivered a 41.72 percent return is 2020 so far. The scheme's current net assets value at Rs 3,496 crore.
SBI Healthcare Opportunities Fund delivered a 40.75 percent return is 2020 so far. The scheme's current net assets value at Rs 1,284 crore.
_2020091018165303jzv.jpg "Decoding The World Of ETF")
CBI books UK-based Cambridge Analytica for 'illegally harvesting data' of Facebook users in India Watch more 
Ideas For Profit | Hamara Bajaj: Strong export demand of two-wheelers, long-term positive outlook Watch more 
Bharat Biotech's Covaxin found to be safe, induced immune response in Phase-1 Watch more 
5 die in Serum Institute of India fire in Pune; no impact on Covishield Watch more 
